126 related articles for article (PubMed ID: 11706708)
1. Catalytic activities and functional effects of Bence Jones proteins.
Sinohara H; Matsuura K
Chem Immunol; 2000; 77():89-101. PubMed ID: 11706708
[No Abstract] [Full Text] [Related]
2. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma?
Sinohara H; Matsuura K
Appl Biochem Biotechnol; 2000; 83(1-3):85-92; discussion 93-4, 145-53. PubMed ID: 10826951
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects.
Matsuura K; Ohara K; Munakata H; Hifumi E; Uda T
Biol Chem; 2006 May; 387(5):543-8. PubMed ID: 16740125
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between the catalysis of Bence Jones protein and renal impairment in patients with multiple myeloma].
Zhou X; Zhai YP; Mei JG; An ZM; Zhou XG; Shi P; Yu YP; Liu HN; Song P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):339-43. PubMed ID: 22541094
[TBL] [Abstract][Full Text] [Related]
5. [Catalytic activity of Bence Jones proteins in renal impairment of patients with multiple myeloma - review].
Zhou X; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):796-800. PubMed ID: 22739205
[TBL] [Abstract][Full Text] [Related]
6. Use of a renal tubule cell line (LLC-PK1) to study the nephrotoxic potential of a kappa-type Bence-Jones protein.
Diemert MC; Tricottet V; Benel L; Descamps G; Escolano E; Galli J; Reynès M; Rousselet F
In Vitro Cell Dev Biol Anim; 1995 Oct; 31(9):716-23. PubMed ID: 8564084
[TBL] [Abstract][Full Text] [Related]
7. The development of cast nephropathy in multiple myeloma.
Iggo N; Winearls CG; Davies DR
QJM; 1997 Nov; 90(11):653-6. PubMed ID: 9474345
[No Abstract] [Full Text] [Related]
8. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
9. Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond.
Matsuura K; Sinohara H
Biol Chem; 1996 Sep; 377(9):587-9. PubMed ID: 9067257
[TBL] [Abstract][Full Text] [Related]
10. V-domain deposition of lambda Bence Jones protein in the renal tubular epithelial cells in a patient with the adult Fanconi syndrome with myeloma.
Isobe T; Kametani F; Shinoda T
Amyloid; 1998 Jun; 5(2):117-20. PubMed ID: 9686306
[TBL] [Abstract][Full Text] [Related]
11. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment.
Paul S; Li L; Kalaga R; Wilkins-Stevens P; Stevens FJ; Solomon A
J Biol Chem; 1995 Jun; 270(25):15257-61. PubMed ID: 7797511
[TBL] [Abstract][Full Text] [Related]
12. Some Bence-Jones proteins enter cultured renal tubular cells, reach nuclei and induce cell death.
Matsuura K; Ikoma S; Watanabe M; Togawa A; Sinohara H
Immunology; 1999 Dec; 98(4):584-9. PubMed ID: 10594692
[TBL] [Abstract][Full Text] [Related]
13. Improvement of catalytic antibody activity by protease processing.
Ohara K; Munakata H; Hifumi E; Uda T; Matsuura K
Biochem Biophys Res Commun; 2004 Mar; 315(3):612-6. PubMed ID: 14975745
[TBL] [Abstract][Full Text] [Related]
14. [A case of Bence-Jones protein myeloma associated with amyloidosis].
Kurisu A; Takemasa Y
Nihon Naika Gakkai Zasshi; 1968 Nov; 57(11):1403-7. PubMed ID: 5752976
[No Abstract] [Full Text] [Related]
15. Amidase activity of human Bence Jones proteins.
Matsuura K; Yamamoto K; Sinohara H
Biochem Biophys Res Commun; 1994 Oct; 204(1):57-62. PubMed ID: 7945392
[TBL] [Abstract][Full Text] [Related]
16. The action of collagenase on K-type Bence-Jones proteins.
Vallet B; Tonnelle C; Coletti-Previero MA
Pathol Biol (Paris); 1977 Jun; 25(6):369-73. PubMed ID: 199879
[TBL] [Abstract][Full Text] [Related]
17. Clearances of Bence-Jones proteins during peritoneal dialysis or plasmapheresis in myelomatosis associated with renal failure.
Sølling K; Sølling J
Contrib Nephrol; 1988; 68():259-62. PubMed ID: 3234000
[No Abstract] [Full Text] [Related]
18. Formation of Bence-Jones protein and myeloma protein in vitro by the plasma-cell tumour MPC-2.
ASKONAS BA; FAHEY JL
Biochem J; 1961 Aug; 80(2):261-8. PubMed ID: 14448393
[No Abstract] [Full Text] [Related]
19. [Early treatment of a Bence-Jones-kappa-light-chain-paraproteinemia].
Bethge WA; Einsele H
Internist (Berl); 2004 Apr; 45(4):466-7. PubMed ID: 15152615
[No Abstract] [Full Text] [Related]
20. Synthesis and metabolism of Bence Jones protein and calculation of tumour burden in patients with Bence Jones myeloma.
Durie BG; Cole PW; Chen HS; Himmelstein KJ; Salmon SE
Br J Haematol; 1981 Jan; 47(1):7-19. PubMed ID: 7437347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
